
NorstellaLinQ data source added to Atropos Evidence™ Network, scoring in the top decile for data quality on Real World Fitness Score®
Published on February 4, 2025
Palo Alto, CA – February 4, 2025 – Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence (RWE) for care, announces the availability of an initial dataset from NorstellaLinQ on the Atropos Evidence Network. NorstellaLinQ, built by Norstella, one of the largest global pharma intelligence solution providers, is the first and only fully integrated data asset combining real-world data (RWD) and proprietary intelligence from the most trusted brands in the industry, paving the way for breakthroughs in drug development and commercialization.
